Matthew Harrison
Stock Analyst at Morgan Stanley
(3.48)
# 895
Out of 5,124 analysts
710
Total ratings
49.65%
Success rate
4.21%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $768 → $769 | $785.51 | -2.10% | 59 | Feb 2, 2026 | |
| INSM Insmed | Maintains: Equal-Weight | $157 → $162 | $149.86 | +8.10% | 20 | Jan 30, 2026 | |
| GILD Gilead Sciences | Maintains: Overweight | $151 → $150 | $152.50 | -1.64% | 44 | Jan 13, 2026 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $41.01 | -31.72% | 27 | Dec 12, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $83 → $50 | $17.10 | +192.40% | 14 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $201.18 | -22.46% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $811.45 | +36.79% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $26.42 | +55.19% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $2.39 | +67.36% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $58.13 | +68.59% | 23 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $30 | $21.08 | +42.31% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.35 | +1,042.86% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $477.92 | -8.14% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $18.50 | +8.11% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $217.50 | -1.15% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $4.16 | +44.40% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.81 | +516.14% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $38.76 | +44.48% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $31.37 | +75.33% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.96 | +53.06% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $23.49 | -53.17% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.82 | +284.62% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $30.90 | +3.56% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.57 | +432.21% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.59 | -37.11% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $21.80 | -54.13% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $9.74 | -17.86% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $33.36 | +31.89% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.93 | +230.79% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $22.72 | +252.11% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.77 | +939.86% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $106.62 | +102.59% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.01 | +24.69% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.63 | +90.11% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $223.43 | -18.54% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $23.04 | -60.94% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $384.32 | -26.62% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $328.16 | -36.01% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $27.22 | +91.04% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $239.99 | -27.91% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $24.70 | +385.83% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $11.60 | +1,175.86% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $121.93 | -32.75% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $61.99 | +6.47% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.61 | +745.99% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $44.65 | +3.02% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $8.21 | +326.31% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,058.18 | -74.01% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $3.17 | +499.37% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $10.33 | +500.19% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $19.27 | -10.48% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $108.39 | -23.42% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $62.34 | -83.96% | 4 | Sep 10, 2018 |
Regeneron Pharmaceuticals
Feb 2, 2026
Maintains: Equal-Weight
Price Target: $768 → $769
Current: $785.51
Upside: -2.10%
Insmed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $157 → $162
Current: $149.86
Upside: +8.10%
Gilead Sciences
Jan 13, 2026
Maintains: Overweight
Price Target: $151 → $150
Current: $152.50
Upside: -1.64%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $41.01
Upside: -31.72%
Legend Biotech
Dec 12, 2025
Maintains: Overweight
Price Target: $83 → $50
Current: $17.10
Upside: +192.40%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $201.18
Upside: -22.46%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $811.45
Upside: +36.79%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $26.42
Upside: +55.19%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $2.39
Upside: +67.36%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $58.13
Upside: +68.59%
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $21.08
Upside: +42.31%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.35
Upside: +1,042.86%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $477.92
Upside: -8.14%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $18.50
Upside: +8.11%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $217.50
Upside: -1.15%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $4.16
Upside: +44.40%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.81
Upside: +516.14%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $38.76
Upside: +44.48%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $31.37
Upside: +75.33%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.96
Upside: +53.06%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $23.49
Upside: -53.17%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.82
Upside: +284.62%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $30.90
Upside: +3.56%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.57
Upside: +432.21%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.59
Upside: -37.11%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $21.80
Upside: -54.13%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $9.74
Upside: -17.86%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $33.36
Upside: +31.89%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.93
Upside: +230.79%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $22.72
Upside: +252.11%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.77
Upside: +939.86%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $106.62
Upside: +102.59%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.01
Upside: +24.69%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.63
Upside: +90.11%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $223.43
Upside: -18.54%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $23.04
Upside: -60.94%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $384.32
Upside: -26.62%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $328.16
Upside: -36.01%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $27.22
Upside: +91.04%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $239.99
Upside: -27.91%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $24.70
Upside: +385.83%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $11.60
Upside: +1,175.86%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $121.93
Upside: -32.75%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $61.99
Upside: +6.47%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.61
Upside: +745.99%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $44.65
Upside: +3.02%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $8.21
Upside: +326.31%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,058.18
Upside: -74.01%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $3.17
Upside: +499.37%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $10.33
Upside: +500.19%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $19.27
Upside: -10.48%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $108.39
Upside: -23.42%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $62.34
Upside: -83.96%